Previous 10 | Next 10 |
BETHESDA, Md., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced the pricing of an underwritten public offering of 2,213,044 shares of its common stock and warrants to purchase up to an aggregate of ...
2023-11-20 17:34:17 ET Symbotic ( SYM ) +20% . Veradigm ( MDRX ) +6% . Tactile Systems Technology ( TCMD ) +6% . Farmer Brothers Company ( FARM ) +4% . Outset Medical ( OM ) +4% . MorphoSys ( MOR ) -32% ...
2023-11-20 16:08:32 ET More on Gain Therapeutics Seeking Alpha’s Quant Rating on Gain Therapeutics Historical earnings data for Gain Therapeutics Financial information for Gain Therapeutics For further details see: Gain Therapeutics intends to offe...
BETHESDA, Md., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock and warrants to purchase common ...
2023-11-14 09:02:00 ET More on Gain Therapeutics Seeking Alpha’s Quant Rating on Gain Therapeutics Historical earnings data for Gain Therapeutics Financial information for Gain Therapeutics For further details see: Gain Therapeutics GAAP EPS of -$0.37
BETHESDA, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announc...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
Gain Therapeutics Inc. (GANX) is expected to report $-0.47 for Q3 2023
2023-10-04 09:46:09 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apple (NASDAQ: AAPL ) stock is a hot topic among traders on Wednesday after several insiders in the tech giant sold shares. One thing that traders will keep in mind is that ...
2023-10-04 09:11:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nvni Group (NASDAQ: NVNI ) stock is falling on Wednesday after the company recently made its public debut following a special purpose acquisition company (SPAC) merger. ...
News, Short Squeeze, Breakout and More Instantly...
Gain Therapeutics Inc. Company Name:
GANX Stock Symbol:
NASDAQ Market:
Gain Therapeutics Inc. Website:
GT-02287 Well Tolerated With No Serious Adverse Events or Other Safety Signals Reported Additional Topline Data To Be Presented Mid-August GT-02287 on Track To Initiate Clinical Trial in Parkinson’s Disease Patients in Q4 2024 BETHESDA, Md., July 09, 2024 (GLOBE NEWSW...
BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announc...